Sqz Biotechnologies's

• SQZB's Stock Performance relative to its Competitors

Tradeup Acquisition Corp Share Performance -5.23% Over The Past 5 Days

Tradeup Acquisition Corp Profile Estrella Immunopharma Inc is a biotechnology company that focuses on developing innovative immunotherapies. They have a business model centered around researching, developing, and commercializing novel treatments for various diseases. Their approach includes leveraging the power of the immune system to target and eradicate diseases, with a particular emphasis on cancer. More about Tradeup Acquisition Corp's Market Share

Black Diamond Therapeutics Inc Share Performance -5.31% This Quarter

Black Diamond Therapeutics Inc Profile Black Diamond Therapeutics Inc's business model is centered around developing targeted therapies for cancer patients by leveraging its proprietary platform and expertise in precision medicine. More about Black Diamond Therapeutics Inc 's Market Share

Omega Therapeutics Inc Share Performance -71.98% 30 Days

Omega Therapeutics Inc Profile Omega Therapeutics Inc is a biotechnology company that focuses on developing therapies by leveraging the power of epigenetics. Their business model involves utilizing their proprietary Omega Epigenomic Programming technology to target specific genes and modulate their activity, addressing complex diseases at their source. By creating innovative and precise therapeutic interventions, Omega Therapeutics aims to make significant advancements in healthcare. More about Omega Therapeutics Inc 's Market Share

Armata Pharmaceuticals Inc Share Performance -31.15% This Quarter

Armata Pharmaceuticals Inc Profile Armata Pharmaceuticals Inc operates on a research and development business model focused on discovering and developing bacteriophage-based therapies to combat antibiotic-resistant infections. They utilize their proprietary phage technology platform to create novel pharmaceutical products targeting various bacterial diseases. More about Armata Pharmaceuticals Inc 's Market Share

Allogene Therapeutics Inc Share Performance +76.79% One Year

Allogene Therapeutics Inc Profile Allogene Therapeutics Inc has a business model that focuses on developing and commercializing innovative allogeneic CAR T cell therapies for the treatment of cancer. More about Allogene Therapeutics Inc 's Market Share

Sources: Sqz Biotechnologies Company’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Wednesday, September 2, 2026 8:50 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sqz Biotechnologies Company versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.